Third Generation IVF Guide

Third-generation IVF usually refers to IVF combined with preimplantation genetic testing, or PGT. The goal is not simply to use a more advanced label. The goal is to understand embryo genetic risk, chromosome risk, and transfer strategy before choosing which embryo to transfer.

IVF with PGT may be considered for patients with advanced reproductive age, recurrent miscarriage, repeated implantation failure, known family genetic conditions, or chromosome structural rearrangements in either partner. Whether PGT is useful depends on age, ovarian reserve, previous cycle history, embryo number, and the specific genetic question being asked.

Basic treatment flow

A typical IVF with PGT pathway includes:

Pre-treatment assessment: ovarian reserve, antral follicle count, hormones, semen analysis, and genetic risk review;
Ovarian stimulation and egg retrieval: medication is adjusted according to ovarian response;
Fertilization and embryo culture: embryos are created through IVF or ICSI and monitored in the laboratory;
Blastocyst culture and biopsy: a small cell sample is usually taken from a blastocyst-stage embryo;
PGT testing: the team selects PGT-A, PGT-M, or PGT-SR according to the indication;
Embryo transfer: timing is planned around embryo results, lining status, and hormone readiness.

What to clarify before starting

The key question is not whether PGT is available. The key question is whether it will change the treatment decision.

Before starting, discuss:

How many eggs and blastocysts may realistically be available;
Whether the concern is chromosome copy number, a single-gene condition, or a structural chromosome issue;
The laboratory’s blastocyst formation, embryo biopsy, and freeze-thaw workflow;
What happens if results include mosaic embryos or no transferable embryos;
Whether a fresh transfer, frozen transfer, or additional cycle planning is more appropriate.

PGT is a selection tool, not a guarantee

PGT can help prioritize embryos for transfer, but it does not improve egg quality, guarantee implantation, or replace good laboratory and transfer planning. A stronger strategy usually comes from combining embryo genetics with ovarian response, sperm factors, endometrial preparation, and cycle timing.